• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转运体在药物相互作用中的作用。

Role of transporters in drug interactions.

机构信息

College of Pharmacy, Dongguk University, Seoul 100-715, Korea.

出版信息

Arch Pharm Res. 2011 Nov;34(11):1865-77. doi: 10.1007/s12272-011-1107-y. Epub 2011 Dec 3.

DOI:10.1007/s12272-011-1107-y
PMID:22139686
Abstract

Over the past few decades, a tremendous amount of work has been done on the molecular characterization of transport proteins in animals and humans, leading to a better understanding of the physiological roles of a number of transport proteins. Furthermore, there is increasing preclinical and clinical evidence to support the importance of transport proteins in the pharmacokinetics and toxicokinetics of a wide variety of structurally diverse drugs. As a consequence, the degree of expression and functionality of transport proteins may directly affect the therapeutic effectiveness, safety and target specificity of drugs. Recently, there has also been increased awareness about potential drug-drug, drug-herb and drug-food interactions involving transporters. Traditionally, a change in metabolic clearance of a drug, particularly via cytochrome P450-mediated metabolism, has been considered the cause of many clinically important drug interactions. However, increasing evidence suggests that some drug interactions result from changes in the activity and/or expression of drug transporters. Accordingly, assessment of the clinical relevance of transporter-mediated drug interactions has become a regulatory issue during the drug approval process and also the evaluation of drug interaction potential has become an integral part of risk assessment during drug development processes. Therefore, this review will highlight the role of some selected drug transporters in drug interactions, as well as their clinical implication.

摘要

在过去的几十年中,人们对动物和人类的转运蛋白的分子特征进行了大量的研究,从而更好地了解了许多转运蛋白的生理作用。此外,越来越多的临床前和临床证据支持转运蛋白在广泛的结构多样的药物的药代动力学和毒代动力学中的重要性。因此,转运蛋白的表达和功能程度可能直接影响药物的治疗效果、安全性和靶标特异性。最近,人们也越来越意识到涉及转运蛋白的药物-药物、药物-草药和药物-食物相互作用的潜在可能性。传统上,药物代谢清除率的变化,特别是通过细胞色素 P450 介导的代谢,被认为是许多临床上重要的药物相互作用的原因。然而,越来越多的证据表明,一些药物相互作用是由于药物转运蛋白的活性和/或表达的变化引起的。因此,评估转运体介导的药物相互作用的临床相关性已成为药物审批过程中的一个监管问题,同时药物相互作用潜力的评估也已成为药物开发过程中风险评估的一个组成部分。因此,这篇综述将重点介绍一些选定的药物转运体在药物相互作用中的作用及其临床意义。

相似文献

1
Role of transporters in drug interactions.转运体在药物相互作用中的作用。
Arch Pharm Res. 2011 Nov;34(11):1865-77. doi: 10.1007/s12272-011-1107-y. Epub 2011 Dec 3.
2
Evaluation of metabolism-mediated herb-drug interactions.代谢相关的中药-西药相互作用评价。
Arch Pharm Res. 2011 Nov;34(11):1829-42. doi: 10.1007/s12272-011-1105-0. Epub 2011 Dec 3.
3
The kidney--the body's playground for drugs: an overview of renal drug handling with selected clinical correlates.肾脏——人体的药物作用场所:肾脏药物处理概述及相关临床实例
Can J Clin Pharmacol. 2003 Spring;10(1):17-23.
4
Herb-drug interactions: focus on metabolic enzymes and transporters.中药-药物相互作用:重点关注代谢酶和转运体。
Arch Pharm Res. 2011 Nov;34(11):1843-63. doi: 10.1007/s12272-011-1106-z. Epub 2011 Dec 3.
5
Transporters as a determinant of drug clearance and tissue distribution.转运体作为药物清除率和组织分布的决定因素。
Eur J Pharm Sci. 2006 Apr;27(5):425-46. doi: 10.1016/j.ejps.2005.12.003. Epub 2006 Feb 20.
6
P-Glycoprotein- and cytochrome P-450-mediated herbal drug interactions.P-糖蛋白和细胞色素P-450介导的草药药物相互作用。
Drug Metabol Drug Interact. 2010;25(1-4):3-16. doi: 10.1515/DMDI.2010.006.
7
Concise review: Clinical relevance of drug drug and herb drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein).简要综述:由ABC转运蛋白ABCB1(多药耐药蛋白1,P-糖蛋白)介导的药物-药物及草药-药物相互作用的临床相关性
Oncologist. 2007 Aug;12(8):927-41. doi: 10.1634/theoncologist.12-8-927.
8
Importance of P-glycoprotein for drug-drug interactions.P-糖蛋白在药物相互作用中的重要性。
Handb Exp Pharmacol. 2011(201):285-97. doi: 10.1007/978-3-642-14541-4_7.
9
Nonrenal drug clearance in CKD: Searching for the path less traveled.慢性肾脏病中非肾脏药物清除:寻找未走过的路。
Adv Chronic Kidney Dis. 2010 Sep;17(5):384-91. doi: 10.1053/j.ackd.2010.05.009.
10
Impact of drug transporter studies on drug discovery and development.药物转运体研究对药物发现与开发的影响。
Pharmacol Rev. 2003 Sep;55(3):425-61. doi: 10.1124/pr.55.3.1. Epub 2003 Jul 17.

引用本文的文献

1
Impacts of Drug Interactions on Pharmacokinetics and the Brain Transporters: A Recent Review of Natural Compound-Drug Interactions in Brain Disorders.药物相互作用对药代动力学和脑转运体的影响:脑疾病中天然化合物-药物相互作用的最新综述。
Int J Mol Sci. 2021 Feb 11;22(4):1809. doi: 10.3390/ijms22041809.
2
Multifaceted Factors Causing Conflicting Outcomes in Herb-Drug Interactions.导致草药-药物相互作用产生矛盾结果的多方面因素。
Pharmaceutics. 2020 Dec 30;13(1):43. doi: 10.3390/pharmaceutics13010043.
3
Glutamine transporters as pharmacological targets: From function to drug design.
谷氨酰胺转运体作为药理学靶点:从功能到药物设计
Asian J Pharm Sci. 2020 Mar;15(2):207-219. doi: 10.1016/j.ajps.2020.02.005. Epub 2020 Mar 5.
4
Organic solute carrier 22 (SLC22) family: Potential for interactions with food, herbal/dietary supplements, endogenous compounds, and drugs.有机溶质载体 22(SLC22)家族:与食物、草药/膳食补充剂、内源性化合物和药物相互作用的潜力。
J Food Drug Anal. 2018 Apr;26(2S):S45-S60. doi: 10.1016/j.jfda.2018.03.002. Epub 2018 Mar 24.
5
A regulatory science viewpoint on botanical-drug interactions.从监管科学角度看植物药药物相互作用。
J Food Drug Anal. 2018 Apr;26(2S):S12-S25. doi: 10.1016/j.jfda.2018.01.013. Epub 2018 Feb 15.
6
Nucleotide Reverse Transcriptase Inhibitors: A Thorough Review, Present Status and Future Perspective as HIV Therapeutics.核苷酸逆转录酶抑制剂:作为抗艾滋病毒疗法的全面综述、现状与未来展望
Curr HIV Res. 2017;15(6):411-421. doi: 10.2174/1570162X15666171120110145.
7
Antiretroviral Therapy and Alcohol Interactions: X-raying Testicular and Seminal Parameters Under the HAART Era.抗逆转录病毒疗法与酒精的相互作用:透视高效抗逆转录病毒治疗时代的睾丸和精液参数
Eur J Drug Metab Pharmacokinet. 2018 Apr;43(2):121-135. doi: 10.1007/s13318-017-0438-6.
8
MDR1 and BCRP Transporter-Mediated Drug-Drug Interaction between Rilpivirine and Abacavir and Effect on Intestinal Absorption.MDR1 和 BCRP 转运蛋白介导的利匹韦林与阿巴卡韦的药物-药物相互作用及其对肠道吸收的影响。
Antimicrob Agents Chemother. 2017 Aug 24;61(9). doi: 10.1128/AAC.00837-17. Print 2017 Sep.
9
Tenofovir Disoproxil Fumarate Is a New Substrate of ATP-Binding Cassette Subfamily C Member 11.富马酸替诺福韦二吡呋酯是ATP结合盒转运蛋白C亚家族成员11的新底物。
Antimicrob Agents Chemother. 2017 Mar 24;61(4). doi: 10.1128/AAC.01725-16. Print 2017 Apr.
10
Drug-Drug Interactions of a Novel κ-Opioid Receptor Agonist, Nalfurafine Hydrochloride, Involving the P-Glycoprotein.一种新型κ-阿片受体激动剂盐酸纳呋拉啡与P-糖蛋白的药物相互作用
Eur J Drug Metab Pharmacokinet. 2016 Oct;41(5):549-58. doi: 10.1007/s13318-015-0286-1.